The Centre for Menstrual Cycle and Ovulation Research (CeMCOR) in Vancouver has published the results of their randomized controlled trial of oral micronized progesterone (Prometrium, 300 mg at bedtime) for hot flushes and night sweats in healthy postmenopausal women
Their research finds that oral micronized progesterone offers an additional and effective therapeutic option for the treatment of hot flushes and night sweats in healthy women early in postmenopause.
They were studying progesterone, which, unlike medroxyprogesterone, does not increase venous thromboembolism.
The researchers do state that further research is needed (the study was small, 133 women) and that the trial “needs replication in less selected, more ethnically diverse populations, and in perimenopausal women.”
Read the article below, as it appears in Menopause: The Journal of The North American Menopause Society, Vol. 19, No. 8, pp. 000/000, DOI: 10.1097/gme.0b013e318247f07
Menopause: The Journal of The North American Menopause Society
Vol. 19, No. 8, pp. 000/000
DOI: 10.1097/gme.0b013e318247f07